MEDTOX Scientific, Inc. is engaged throughout the United States in two distinct, but related businesses - forensic and clinical laboratory services to corporations, pharmaceutical companies and health care organizations (the Laboratory segment), and the manufacturing and distribution of diagnostic drug screening devices (the Diagnostic segment). MEDTOX Laboratories, Inc., is the Laboratory segment in St. Paul, MN, and is the nation's third largest SAMHSA-certified drug testing laboratory. It operates an extensive CAP-accredited clinical and occupational testing laboratory. MEDTOX has developed over 900 individual assays for use in bio-analytical studies for the pharmaceutical industry. MEDTOX Laboratories can provide pharmaceutical sponsors all required services for their Phase 1 - Phase 4 clinical trials. Through MEDTOX Diagnostics, Inc. (the Diagnostic segment) in Burlington, NC, MEDTOX manufactures 20 FDA-cleared diagnostic drug screening devices for use in corporate, corrections, rehabilitation and clinical trial programs.
MEDTOX Scientific, Inc. Investor Relations 877-715-7236
Basic Industries: Lab & POC Diagnostic Drug Testing, Clinical Trials, Clinical Toxicology, Lead Screening, Lab Services
MEDTOX Focus: Building a Business within Laboratory and Diagnostic Testing Markets
NASDAQ Symbol: MTOX
NASDAQ Fundamentals
Vital Statistics - Year-End 2007
2007 Revenue: $80.3 Million
2007 EPS: $0.75
Shares Outstanding: 8,434,850
Approximate Public Float: 7,520,000
Insider Ownership: 11%
Institutional Ownership: 59%
Fiscal Year End: December 31